AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Once $5 billion IPO bound, Cybereason merges with Trustwave amid decline
4
"The next phase for Miami will be an increase in exits"
5
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
More news

Biotech

20 stories about Biotech
Yael Porat

BioGenCell raises $16 million Seed round led by Marius Nacht for microvascular diseases treatment

09.05.22|Meir Orbach
The Israeli startup uses stem cells from the patient’s own blood to treat microvascular diseases and is aiming to develop products that may be usable to restore tissues damaged by diabetes, kidney failure, pulmonary hypertension, heart failure, stroke, blindness, and more
מריוס נכט

Marius Nacht: "I won’t have another success in high-tech like Check Point, but in biotech I will"

25.04.22|Meir Orbach and Diana Bahur Nir
Marius Nacht is one of the founding fathers of Israeli cybersecurity, but in recent years he has preferred to invest in biotech. In an exclusive interview with Calcalist, he tells how his interest in the life sciences arose, why it’s important to make long-term investments in Israeli companies, and why he left the digital bank and parted ways with the aMoon fund
Kirill Pevzner and Eran Seger Protai

Protai raises $8 million in Seed for its proteomics-based platform for drug discovery

05.01.22|James Spiro
The company has developed an end-to-end AI-based platform that can map the course of a disease on the protein level
Noam Solomon Immunai

When not knowing is a methodology

05.01.22|Noam Solomon
"When your culture celebrates that knowledge always starts from the lack thereof, people are rewarded for asking the right questions and not just for knowing the answers," writes Noam Solomon, CEO & Co-Founder of Immunai
צוות Nucleai מימין לוטן חורב אלירון אמיר אבי ויידמן אלברט אכטרברג

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22|Yafit Ovadia
Nucleai is looking at the way cells interplay and are interspersed within human tissue to develop precision medicine solutions
ועידת היוניקורנס Noam Solomon

“What we are building is the Google Maps for the human immune system”

16.12.21|James Spiro
Speaking at the Unicorn Forum, Noam Solomon, CEO of Immunai, outlined an exciting prospect for the future of human health
מימין מריוס נכט וד"ר עידו בצ'לט

Mysterious Israeli biotech company raises $120 million Seed round five months after founding

08.12.21|Golan Hazani
The company named 1E Therapeutics was founded by Dr. Ido Bachelet and has received investments from the likes of Marius Nacht. It employs dozens of scientists working on an unspecified project related to drug development
מייסדי Immunai מימין לואיס וולוך ו נועם סולומון

Biotech startup Immunai earns unicorn status with $215 million Series B

27.10.21|Meir Orbach
The Israeli company has developed a technological platform that maps the entire immune system for better detection, diagnosis, and treatment of disease
פיני אורבך ואלון לזרוס ארקין ביו קפיטל

Arkin Holdings raises $270 million for new biotech fund

27.10.21|Meir Orbach
The new fund, which will be named Arkin Bio-Capital, intends to invest in 8-10 companies that are developing innovative medicine and plan on going public in the near future
דוד וחוזה איצקוביץ מילאוטיס

The Israeli startup combating drug-resistant bacteria

24.10.21|Yafit Ovadia
“Some 70% of antibiotics worldwide are administered to animals, and affected pathogens may later develop antimicrobial resistance and enter the environment, affecting humans,” says David Javier Iscovich, the CEO of Mileutis, which has developed an antibiotic-alternative for dairy cows and animal health
אייבקס אנליטיקס ibex analytics

Roche partners with Ibex Medical Analytics for AI-assisted cancer detection

18.10.21|CTech
The Israeli AI-based cancer diagnostics startup will jointly develop an embedded image analysis workflow for pathologists to help diagnose early cancer detection
תמר ון דר באום ו יואב אלקלעי ממשרד פרל כהן

The path to Wall Street is paved with patents for Biotech companies

29.09.21|Tamar van der Boom and Yoav Alkalay
"Building a useful patent portfolio requires the company to define quantity and quality targets, for the short, medium, and long terms," write Tamar van der Boom and Yoav Alkalay of Pearl Cohen law firm
שינוי אקלים

Saving the planet, one innovation at a time

20.09.21|Yafit Ovadia
The Smart Agro R&D Partnership invests in Israeli agritech, foodtech, and other sustainable technologies to save food sources, namely plants and bees. “We’re solving big issues with technology,” said CEO Dganit Vered
Betalin Therapeutics Nikolai Kunicher

Betalin Therapeutics receives EU equity investment for its alternative insulin therapy

21.07.21|James Spiro
The Biomed startup seeks to eliminate the need for insulin injections and glucose testing
מימין דוקטור יהושוע גלייטמן אבנר לושי ופרופסור שלמה נו

Shuki Gleitman's GIBF raising $300 million in China for second biotech fund

31.05.21|Golan Hazani
The Guangzhou Sino-Israel Biotech Investment Fund (GIBF) focuses on life science investments and cooperates with leading Guangzhou organizations to bring Israeli biotech firms to the massive Chinese metropolitan
איתן סטיבה בכנס הכרזת הניסויים

Which Israeli technologies will soon be going to space?

05.05.21|Yafit Ovadia
Space Hummus, onboard drones, flexible solar panels, and cameras to photograph “lightning elves” are just some of the Israeli technologies that will accompany the next Israeli astronaut to space in 2022
מימין: ד״ר דוד סידרנסקי עידו צאירי ד״ר יובל קבילי קרן השקעות Israel Biotech Fund

Israel Biotech Fund ready to expand portfolio after closing $112 million second fund

05.04.21|Meir Orbach
The fund will focus on the investment and formation of Israeli biotech and pharma companies developing drugs at different stages of development and for various indications
גילי רגב מנכ"לית סנוטייז

Israel and New Zealand approve anti-Covid-19 nasal spray

23.03.21|Reuters
Both countries granted approval for the sale of Canadian biotech company SaNOtize’s nasal spray, which has proven effective at preventing spread of virus
עפר גונן מנכ"ל כלל ביוטכנולוגיה

CBI plans to issue new SPAC to merge with Israeli life science company

18.03.21|Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
משרדי בורסת נאסד"ק ב ניו יורק

ForeBio is on its way to Nasdaq at a $500 million valuation

01.03.21|Tzally Greenberg
The company aims to raise $100 million in an April IPO, while Pontifax and OrbiMed who previously invested $21 million for a 12.5% stake in ForeBio’s shares are expected to make a $120 million profit
Previous ArticlesMore Articles